175
- Silverberg MJ, Chao C, Leyden WA, Xu L, Tang B, Horberg MA, Klein D, Quesenberry CP Jr,
Towner WJ, Abrams DI (2009) HIV infection and the risk of cancers with and without a known
infectious cause. AIDS. (London, England 23:2337 - Clifford GM, Polesel J, Rickenbach M, Dal Maso L, Keiser O, Kofler A, Rapiti E, Levi F, Jundt
G, Fisch T (2005) Cancer risk in the Swiss HIV cohort study: associations with immunodefi-
ciency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst 97:425–432 - Goedert JJ, Coté TR, Virgo P, Scoppa SM, Kingma DW, Gail MH, Jaffe ES, Biggar RJ, Group
A-CMS (1998) Spectrum of AIDS-associated malignant disorders. Lancet 351:1833–1839 - Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM (2007) Incidence of cancers in people
with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis.
Lancet 370:59–67 - Control CfD, Prevention (1993) Impact of the expanded AIDS surveillance case definition
on AIDS case reporting – United States, first quarter, 1993. MMWR Morb Mortal Wkly Rep
42:308 - Consortium WTS (2009) Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-
infected patients: a collaborative analysis of 18 HIV cohort studies. Lancet 373:1352–1363 - Morlat P, Roussillon C, Henard S, Salmon D, Bonnet F, Cacoub P, Georget A, Aouba A,
Rosenthal E, May T (2014) Causes of death among HIV-infected patients in France in 2010
(national survey): trends since 2000. AIDS 28:1181–1191 - Silverberg MJ, Lau B, Achenbach CJ, Jing Y, Althoff KN, D'Souza G, Engels EA, Hessol
NA, Brooks JT, Burchell AN, Gill MJ, Goedert JJ, Hogg R, Horberg MA, Kirk GD, Kitahata
MM, Korthuis PT, Mathews WC, Mayor A, Modur SP, Napravnik S, Novak RM, Patel P,
Rachlis AR, Sterling TR, Willig JH, Justice AC, Moore RD, Dubrow R (2015) Cumulative
incidence of cancer among persons with HIV in North America: a cohort study. Ann Intern
Med 163:507–518 - Bonnet F, Burty C, Lewden C, Costagliola D, May T, Bouteloup V, Rosenthal E, Jougla E,
Cacoub P, Salmon D (2009) Changes in cancer mortality among HIV-infected patients: the
Mortalite 2005 survey. Clin Infect Dis 48:633–639 - Yarchoan R, Tosato G, Little RF (2005) Therapy insight: AIDS-related malignancies—
the influence of antiviral therapy on pathogenesis and management. Nat Clin Pract Oncol
2:406–415 - Jones ME, Swerdlow AJ (1998) Bias in the standardized mortality ratio when using general
population rates to estimate expected number of deaths. Am J Epidemiol 148:1012–1017 - Powles T, Robinson D, Stebbing J, Shamash J, Nelson M, Gazzard B, Mandelia S, Møller H,
Bower M (2009) Highly active antiretroviral therapy and the incidence of non–AIDS-defining
cancers in people with HIV infection. J Clin Oncol 27:884–890 - Shiels MS, Pfeiffer RM, Hall HI, Li J, Goedert JJ, Morton LM, Hartge P, Engels EA (2011)
Proportions of Kaposi sarcoma, selected non-Hodgkin lymphomas, and cervical cancer in the
United States occurring in persons with AIDS, 1980–2007. JAMA 305:1450–1459 - Raffetti E, Albini L, Gotti D, Segala D, Maggiolo F, di Filippo E, Saracino A, Ladisa N,
Lapadula G, Fornabaio C, Castelnuovo F, Casari S, Fabbiani M, Pierotti P, Donato F, Quiros-
Roldan E (2015) Cancer incidence and mortality for all causes in HIV-infected patients over a
quarter century: a multicentre cohort study. BMC Public Health 15:235 - Eltom MA, Jemal A, Mbulaiteye SM, Devesa SS, Biggar RJ (2002) Trends in Kaposi’s sar-
coma and non-Hodgkin’s lymphoma incidence in the United States from 1973 through 1998.
J Natl Cancer Inst 94:1204–1210 - Coté TR, Biggar RJ, Rosenberg PS, Devesa SS, Percy C, Yellin FJ, Lemp G, Hardy C, Geodert
JJ, Blattner WA (1997) Non-Hodgkin’s lymphoma among people with AIDS: incidence, pre-
sentation and public health burden. Int J Cancer 73:645–650 - Park LS, Tate JP, Sigel K, Rimland D, Crothers K, Gibert C, Rodriguez-Barradas MC, Goetz
MB, Bedimo RJ, Brown ST (2016) Time trends in cancer incidence in persons living with
HIV/AIDS in the antiretroviral therapy era: 1997–2012. AIDS, London
10 Malignancies and HIV Infection